Voicing contrast of stop consonant production in the speech of individuals with Parkinson disease ON and OFF dopaminergic medication.

Voicing contrast of stop consonant production in the speech of individuals with Parkinson disease ON and OFF dopaminergic medication. Clin Linguist Phon. 2017 Oct 24;:1-8 Authors: Whitfield JA, Reif A, Goberman AM Abstract The aims of this study were to: 1) compare voicing contrast in speakers with Parkinson disease (PD) and healthy controls by comparing the separation of voice onset time (VOT) distributions of voiced and voiceless stop consonants and 2) to determine whether the administration of dopaminergic medication affected VOT separation in speakers with PD. Data from a previous study by Fisher and Goberman (2010) were used to compare the VOT measures obtained from a group of speakers with PD with both ON and OFF medication, and a group of healthy controls. Supplementing the previous findings, the current analysis revealed that individuals with PD exhibited significantly less contrast between voiced and voiceless VOT than that observed in healthy speakers. Medication administration did not affect VOT contrast as no differences in VOT separation were observed between the ON and OFF medication states. PMID: 29064294 [PubMed - as supplied by publisher]
Source: Clinical Linguistics and Phonetics - Category: Speech-Language Pathology Authors: Tags: Clin Linguist Phon Source Type: research